| Description: | EBV seropositivity for Epstein-Barr Virus |
| Category: | Biological samples ⏵ Blood assays ⏵ Infectious Diseases |
| Biomarkers |
| Participants | 9,683 | Value Type | Categorical (single) | Sexed | Both sexes | Debut | Jun 2018 | |||
| Item count | 9,960 | Item Type | Data | Instances | Defined (2) | Version | Jun 2018 | |||
| Stability | Accruing | Strata | Derived | Array | No | Cost Tier | o1 s2 |
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Instance 1 : First repeat assessment visit (2012-13)
537 participants, 537 items
Defined as positive if: two or more of antigen VCA p18 > 250, antigen EBNA-1 > 250, antigen ZEBRA > 100, antigen EA-D > 100.
| Preview | Name | Res ID |
|---|---|---|
 | Serological measurement of infectious disease pathogens | 1348 |
| Application ID | Title |
|---|---|
| 45925 | Risk Factors, Biomarkers and Impact of Major Vision-Threatening Eye Diseases |
Enabling scientific discoveries that improve human health